Related Experiment Video
Updated: Aug 16, 2026
Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System
Published on: August 8, 2012
[Killing effect of Photofrin-Herceptin immunoconjugate on tumor cell lines in vitro]
Xin-yu Qian1, Rong-cheng Luo, Li-bo Li
1Center of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Objective:
To study the specific killing effect of the Photofrin-Herceptin immunoconjugate on the tumor cells expressing HER-2.
Methods:
Photofrin (porfimer sodium) was covalently coupled to Herceptin (trastuzumab) via [1-ethyl-3-(3-dimethyl-aminopropyl)carbodiimide hydrochloride](EDCI) , and the killing effect of this conjugate was evaluated by means of MTT assay on SK-BR-3, MCF-7 and A549 cell lines expressing HER-2 at different levels.
Results:
The conjugate had weaker immunoactivity than Herceptin, but possessed stronger killing effect on the cell lines expressing HER-2 than Photofrin, Herceptin, as well as the mixture of Photofrin and Herceptin (P<0.05). In the cell lines negative for HER-2 expression, the killing effect of the conjugate was similar to that of Photofrin, Herceptin, and their mixture.
Conclusion:
Photofrin-Herceptin immunoconjugate can specifically kill HER-positive cells in vitro.
